文献速递消化内镜消化道肿瘤与早癌

结肠癌筛查、监测与治疗:新型人工智能驱动策略在结肠病变管理中的应用

Colon Cancer Screening, Surveillance, and Treatment: Novel Artificial Intelligence Driving Strategies in the Management of Colon Lesions.
PubMed 文献 · Gastroenterology · 2025-03-05

本文综述了计算机辅助检测(CADe)与计算机辅助诊断(CADx)在结肠镜检查中的应用。CADe可提高腺瘤检出率,但可能延长操作时间、增加非肿瘤性息肉切除及监测负担;CADx在鉴别小息肉方面有前景,但近端结肠准确性有限、特异性不足且输出为二分类。真实世界数据与试验疗效存在差距,需在非受控环境中进一步研究。

要点

  • CADe可提高腺瘤检出率,但可能延长操作时间、增加非肿瘤性息肉切除和监测负担。
  • CADx鉴别肿瘤性与非肿瘤性小息肉有前景,但近端结肠准确性有限。
  • CADx特异性有限且输出为二分类,需可解释人工智能以获取内镜医师信任。

核心结论

  • CADe在提高腺瘤检出率方面有效,可能降低长期结直肠癌发病率,但伴随操作时间延长、非肿瘤性息肉切除增加和监测负担加重等挑战。
  • CADx在鉴别肿瘤性与非肿瘤性小息肉方面有前景,但准确性存在局限,尤其在近端结肠。
  • 真实世界数据揭示试验疗效与实际结果之间存在差距,强调需在非受控环境中进一步研究。

研究设计与样本

  • 本文为综述,探讨人工智能在结肠癌筛查、监测和治疗中的益处、危害和局限性,聚焦于CADe和CADx系统用于病变检测和表征。

主要发现

  • CADe已被证明可提高腺瘤检出率,可能降低长期结直肠癌发病率。
  • CADe的益处伴随潜在操作时间延长、非肿瘤性息肉切除增加和监测负担加重。
  • CADx在鉴别肿瘤性与非肿瘤性小息肉方面有前景,但在准确性方面存在局限,尤其在近端结肠。
  • 真实世界数据揭示试验疗效与实际结果之间存在差距。
  • CADx特异性有限且输出为二分类,凸显了可解释人工智能对于获得内镜医师信任的必要性。

局限性

  • 真实世界数据揭示试验疗效与实际结果之间存在差距,强调需在非受控环境中进一步研究。
  • CADx准确性存在局限,尤其在近端结肠。
  • CADx特异性有限且输出为二分类。
  • CADe的益处伴随潜在操作时间延长、非肿瘤性息肉切除增加和监测负担加重等挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Colonoscopy, a crucial procedure for detecting and removing colorectal polyps, has seen transformative advancements through the integration of artificial intelligence, specifically in computer-aided detection (CADe) and diagnosis (CADx). These tools enhance real-time detection and characterization of lesions, potentially reducing human error, and standardizing the quality of colonoscopy across endoscopists. CADe has proven effective in increasing adenoma detection rate, potentially reducing long-term colorectal cancer incidence. However, CADe's benefits are accompanied by challenges, such as potentially longer procedure times, increased non-neoplastic polyp resections, and a higher surveillance burden. CADx, although promising in differentiating neoplastic and non-neoplastic diminutive polyps, encounters limitations in accuracy, particularly in the proximal colon. Real-world data also revealed gaps between trial efficacy and practical outcomes, emphasizing the need for further research in uncontrolled settings. Moreover, CADx limited specificity and binary output underscore the necessity for explainable artificial intelligence to gain endoscopists' trust. This review aimed to explore the benefits, harms, and limitations of artificial intelligence for colon cancer screening, surveillance, and treatment focusing on CADe and CADx systems for lesion detection and characterization, respectively, while addressing challenges in integrating these technologies into clinical practice.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Hassan C, Bisschops R, Sharma P, et al. Colon Cancer Screening, Surveillance, and Treatment: Novel Artificial Intelligence Driving Strategies in the Management of Colon Lesions. Gastroenterology. 2025. PMID: 40054749. doi:10.1053/j.gastro.2025.02.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。